Skip to main content Accessibility help
×
Home

Information:

  • Access
  • Cited by 2

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital
        Available formats
        ×
Export citation

Summary

The aim of this study was to determine the burden, management and outcomes of rotavirus infection in young children presenting to a tertiary paediatric hospital in Sydney, Australia. All laboratory-confirmed cases of rotavirus in children aged <5 years were identified and medical records reviewed. In 2004, 80 children aged <5 years presented to the hospital with rotavirus gastroenteritis confirmed by stool testing. Infants aged <24 months comprised 75% of cases, with more males than females affected. Most children (86%) acquired rotavirus infection in the community, with a mean length of hospital admission of 2·3 days. There were eight cases of nosocomial infection at a rate of 3/10 000 admissions. The rates of intravenous fluid management (46%) and antibiotic use (28%) were high, reflecting the severity of disease presenting in a hospital setting. These data will help inform the assessment of the recently introduced rotavirus vaccination programme in Australia.

INTRODUCTION

Rotavirus is the main cause of diarrhoea-related illness and death in children worldwide. It is associated with more than 2·3 million hospitalizations and up to 600 000 deaths in children aged <5 years [1]. In Australia about 20 000 children aged <5 years are admitted to hospital with acute gastroenteritis each year, with rotavirus being responsible in ~50% of cases [2]. The direct medical costs in Australia are estimated at over Aus$30 million annually [2].

Rotavirus infection usually results in acute gastroenteritis characterized by vomiting and severe watery diarrhoea in >90% of cases and fever in 30% [3], often leading to dehydration. Children usually become infected in the first 3–5 years of life with the highest incidence in those aged <2 years [2].

Acute gastroenteritis is a common reason to seek medical attention. A general practitioner consultation is sought in 75% of cases, advice from accident and emergency departments in 50% of cases and from pharmacists in 5% of cases [4]. The mean cost of hospitalization for rotavirus infection is estimated at about Aus$2160 per child and the cost of care in the community at Aus$550 per child [5]. Together with the added costs of missed work and schooling, rotavirus places a large financial burden on the health system and society [5].

Naturally acquired rotavirus infection, protects against subsequent severe disease or re-infection, particularly following repeat exposures [6]. After a single natural infection 40% of children are protected against subsequent infection, 75% are protected against diarrhoea caused by subsequent infection and 88% are protected against severe rotavirus diarrhoea [6]. Second, third and fourth infections provide progressively greater protection. Immunization with oral attenuated rotavirus vaccines aims to duplicate natural protection and prevent moderate to severe disease, using a multi-dose schedule in the first 6 months of life.

Following the withdrawal of an effective rotavirus vaccine licensed in the United States in 1998 due to an association with intussusceptions [7], two live attenuated rotavirus vaccines have been tested in large-scale randomized controlled trials [8, 9]. These two live attenuated oral vaccines were licensed for use in Australia in 2006 and are now funded on the National Immunization Program (NIP) for all Australian infants.

The aim of this study was to collect detailed data on the burden, management and outcomes of rotavirus infection in children aged <5 years who presented to a tertiary paediatric hospital in Australia.

METHODS

All stool samples that were tested for rotavirus antigen by EIA (Vidas; bioMérieux, Marcy l'Etoile, France) in 2004, at the Children's Hospital at Westmead [a tertiary-care paediatric hospital in Sydney, New South Wales (NSW)], were identified from microbiology department records. Medical records were reviewed for those children aged <5 years with a positive or equivocal result who presented to the Children's Hospital at Westmead emergency department or who were in-patients. Data were extracted onto a standard form.

Demographic information on sex, age at presentation and country of birth was collected. Immunization status of patients was assessed as ‘up-to-date’ or incomplete, according to the Australian Standard Vaccination Schedule [10]. The study was conducted prior to the availability of rotavirus vaccines. Children were classified as either breastfed, formula-fed, or if the child was in an older age group (>18 months), this was recorded as not applicable. Date of presentation, onset and duration of symptoms and admission were determined for each patient. The presence of symptoms and signs commonly associated with rotavirus gastroenteritis including diarrhoea, vomiting, fever, lethargy and dehydration were recorded as well as weight loss, a decrease in oral intake and any other symptoms experienced. It was determined whether rotavirus infection was nosocomial (symptoms occurred 3 days after admission for an unrelated illness) or community acquired and whether the child was admitted as an in-patient. Total admissions to the Children's Hospital at Westmead in 2004 (26 029) were obtained. The rate of nosocomial infection per 10 000 admissions was determined.

The number of investigations performed, including blood tests, microbiological culture, radiology and other tests were obtained along with details of medical management. Where stated, it was determined if other health professionals had been consulted prior to presentation and whether any management had been performed at home.

Principal and comorbid diagnoses were verified by checking against the ICD-10-CM [11] coding on discharge. A number of patients who were not assigned official ICD codes were classified with the provisional diagnosis of ‘gastroenteritis, viral’ as assigned on the emergency department record.

Descriptive, univariate analysis was done using SAS software (SAS Institute, Chicago, IL, USA). The study was approved by the Children's Hospital at Westmead Research Ethics Committee (MR 2005-06-07).

RESULTS

A total of 1268 stool samples of children were tested for rotavirus at the Children's Hospital at Westmead in 2004. Eighty-six (7%) children tested positive for rotavirus. Five patients were excluded from the study as they aged >5 years. In one case the same patient tested positive twice on a single admission and was therefore only counted once. The records of 80 patients were reviewed. An additional 39 children had an equivocal result; however, these records were not included in the main analysis.

Figure 1 shows that compared to previous years, the number of positive tests in 2004 was lower. The most cases of rotavirus gastroenteritis were identified in the months of September and October. In 2004 the greatest number of cases occurred in September with 26 positive stool test results.

Fig. 1. Stool samples testing positive or equivocal for rotavirus at the Children's Hospital at Westmead, January 2000 to December 2004.

The age distribution of children with rotavirus is shown in Figure 2. About half of the children (39/80) in the study were aged <12 months and 75% (62/80) were <2 years. The mean age of children with rotavirus-positive stool samples was 13 months. Sixty-one (61%) of the patients were male and thirty-one (39%) female. Ninety percent of children (72 patients) were born in Australia. Only 15 (19%) patients reported contact with others with gastrointestinal symptoms prior to presentation. Immunization status was reported as up-to-date in 75% of cases, incomplete in 18% of patients and in 8% immunization status could not be determined. In those infants in whom the method of feeding was recorded: five children were breastfed at time of presentation compared to 31 formula-fed children.

Fig. 2. Age of 80 children aged <5 years with positive rotavirus stool tests presenting to the Children's Hospital at Westmead, 2004. ■, Male; □, female.

Rotavirus infection was community acquired in 69/80 patients (86%). Nosocomial infection was reported in eight patients (10%) during their hospital admission for causes other than rotavirus gastroenteritis; acquisition was unknown for three patients. Of the 26 029 admissions to the Children's Hospital at Westmead in 2004 nosocomial rotavirus infection occurred at a rate of 3/10 000 hospital admissions. Of the nosocomial cases, four (50%) were aged <12 months. Of those children who were became infected with rotavirus whilst in hospital, the most common presenting symptoms were vomiting (88%), diarrhoea (75%), and fever (63%) with a mean symptom duration of 1·5 days. The principal diagnoses for in-patients who acquired rotavirus during their stay included conditions such as encephalitis, generalized epilepsy and other convulsions. Many of these patients had multiple comorbid diagnoses.

Of the 69 patients who acquired rotavirus in the community, all but one presented to the emergency department. Twenty-six (38%) of those children presenting to emergency were admitted to hospital and the remainder (62%) were treated and discharged from the emergency department. However, of all patients only 27 patients (39%) were discharged within 24 h, with the remainder requiring one or more nights in the hospital or emergency department (Fig. 3). In general, admissions were short with most only requiring 1–3 days as an in-patient (Fig. 3).The mean length of stay for those acquiring rotavirus infection in the community was 2·3 days.

Fig. 3. Length of stay in hospital for 69 children with community-acquired rotavirus presenting to the Children's Hospital at Westmead in 2004 (0 day represents children admitted for <24 h).

In children aged <2 months who acquired rotavirus infection in the community the mean length of stay was 1·5 days compared to 3·0 days in those aged ⩾12 months. Of children aged <12 months, 10/33 (30%) patients were admitted to hospital and the remainder were discharged from emergency.

Most children presented with symptoms of diarrhoea, vomiting and fever (Table 1). Dehydration affected 39% of children. Many patients presented with other symptoms, which included respiratory symptoms, rash and febrile seizures.

Table 1. Presenting symptoms of 69 children testing positive for community-acquired rotavirus gastroenteritis, who presented to the Children's Hospital at Westmead in 2004

All 80 patients in the study had their stools tested for rotavirus and a stool culture performed for bacterial pathogens. For 20 children these were the only tests that were performed. In total, 599 investigations were performed. The frequency and number of investigations are presented in Table 2. The median number of investigations per patient was 4 (mean of 5·5), excluding stool culture and rotavirus antigen testing. Common investigations included assessment of urea, electrolytes and creatinine (UEC), full blood count (FBC) and blood culture. Eleven children required a lumbar puncture and assessment of cerebrospinal fluid as part of a septic work-up.

Table 2. Investigations performed in 80 children that tested positive for rotavirus gastroenteritis at the Children's Hospital at Westmead in 2004*

* Excludes stool culture and rotavirus antigen testing.

Management for rotavirus gastroenteritis included rehydration with oral rehydration solution (ORS) and intravenous (i.v.) fluids and the prescription of antibiotics and other medications including paracetamol (Table 3). Thirty-seven children (46%) received i.v. fluids, most commonly N/2 saline and 2·5% dextrose. Six children received a bolus of normal saline (NS). ORS was given to many patients in the waiting area of the emergency department prior to consultation. A total of 39 (49%) children received ORS, in the form of either gastrolyte or hydrolyte. Five patients were rehydrated with ORS via nasogastric tube.

Table 3. Management performed in 80 children that tested positive for rotavirus gastroenteritis at the Children's Hospital at Westmead in 2004

Antibiotics were prescribed to 22 (28%) patients. The most frequently used antibiotics were cefotaxime, ampicillin and gentamicin. Nine patients received cefotaxime, four had ampicillin, gentamicin or both and three patients were prescribed EES (erythromycin ethyl succinate). Other antibiotics given included; timentin (1 patient), benzyl penicillin (2), vancomycin (1), cephalexin (3) and rifampicin (1). Two patients received the antiviral acyclovir. Thirty-nine patients (49%) were given other medication of which paracetamol was the most common followed by ibuprofen. Two patients received phenobarbitone and five patients presented with the need for salbutamol.

Of all 35 patients managed in hospital, 24 (69%) received i.v. fluids, 20 (57%) received antibiotics and 29 (83%) received other medications. This contrasts with those 43 patients not admitted to the ward where 13 (30%) received i.v. fluids, two (5%) received antibiotics and 10 (23%) received other medications. Fourteen children aged <12 months (36%) were treated with i.v. fluids, 19 (49%) received ORS, 10 (26%) were given antibiotics and 16 (41%) other medications. Of those that were breastfed 60% were managed with i.v. fluids. No breastfed children received antibiotics. No patients required admission to the intensive care unit (ICU) due to rotavirus infection.

Only 12/69 children (17%) with community-acquired infection had management performed at home prior to presentation to hospital. Eleven patients were treated with paracetamol. ORS was given in six cases and 14 (20%) saw a health professional prior to presentation. Two children were prescribed the anti-emetic metoclopromide and one promethazine hydrochloride. Seven patients were taking antibiotics at the time of presentation. In general this was cotrimoxazole at prophylactic doses.

Treatment on discharge was recommended for eight patients. Four patients were prescribed cephalexin for urinary tract infection and three children were changed to a lactose-free formula. Most patients were advised to follow-up with their local general practitioner for review of symptoms and stool analysis. One patient was referred for a small bowel biopsy.

The ICD-10-CM codes for each patient were determined from medical records. Principal diagnostic codes are given in Table 4. The code for rotavirus enteritis (A080) was the principal diagnosis in only 23/80 cases. Those without any official coding (28 patients) were patients with a short stay in the emergency department only. Twenty-six of these patients received a diagnosis of ‘gastroenteritis, viral’ in the emergency department.

Table 4. Frequency of principal ICD-10-CM codes for 80 children that tested positive for rotavirus gastroenteritis at the Children's Hospital at Westmead in 2004

* Other diarrhoea codes include: A09 Diarrhoea and gastroenteritis of presumed infectious origin; A084 Viral intestinal infection, unspecified; R11 Nausea and vomiting.

Where primary diagnostic code did not include A080, A09, A084, R11.

Primary diagnosis assigned in emergency department where record has not been coded with ICD-10.

§ Diagnosis made, no ICD-10 code.

There were 17 patients with a principal code other than rotavirus enteritis or other diarrhoea. Of those with a code other than rotavirus or infectious diarrhoea as the principal diagnosis, seven (9%) had rotavirus enteritis as a comorbid diagnosis and two (2·5%) a non-specific gastroenteritis diagnosis. Nine patients had multiple diagnoses. Two patients had comorbidities resulting in immunosuppression. These included acute lymphoblastic leukaemia in remission and a liver transplant patient.

Discussion

This study demonstrates the burden and outcome of rotavirus infection in children aged <5 years presenting to a tertiary paediatric hospital. Over half of the children in this study were aged <12 months and 75% were <24 months. The high burden of infection in children aged <2 years is consistent with patterns reported in Australia and other developed countries [2, 1215]. A greater number of infections occurred in males than in females [15]. The Australian Rotavirus Surveillance Program reported that 72% of positive rotavirus stool samples serotyped from centres around Australia from 1 July 2003 to 30 June 2004 were from infants aged <24 months [16].

While rotavirus gastroenteritis causes up to an estimated 611 000 deaths worldwide [17], very few deaths occur in developed countries [1]. In this study, there were no deaths or ICU admissions associated with rotavirus infection, however, it is estimated that about one death occurs annually in Australia from rotavirus infection [16].

The average length of stay for children acquiring rotavirus infection in the community was 2·3 days, similar to previous findings [2, 5]. Galati et al. [2] suggested that shorter length of stay in Australia, compared to that seen in the United States (3·9 days) [18], may reflect a less severe spectrum of illness, better management or more widespread use of ORS. This study involved only children who presented to hospital and whose stools were tested for rotavirus and therefore may represent those with more severe disease.

The high use of i.v. fluids (46%) and antibiotics (28%) may also reflect an increased severity of cases and dehydration status. Antibiotics would have been prescribed in infants and young children who were febrile, where the clinical assessment suggested a possible bacterial infection. There were also a relatively large number of children [11] who received a lumbar puncture, which is a diagnostic test often performed in young infants with fever and vomiting. The extensive investigations may have resulted from children presenting with general systemic symptoms of sepsis and consequently having a full septic work-up.

The use of ORS use prior to hospital presentation was low, although 49% of children in the study were given ORS after presenting to hospital. It has been proposed that increased use of ORS would minimize the need for hospitalization, use of i.v. fluids, antibiotics and anti-diarrhoeal and anti-emetic agents [19]. ORS has been shown to be as effective as i.v. fluids in treating children with mild to moderate dehydration with fewer side-effects [20, 21]. In NSW management of gastroenteritis in infants is directed by clinical practice guidelines published by the NSW Department of Health [22]. Oral rehydration via oral or nasogastric fluid is the recommended route for cases of mild to moderate dehydration. Use of anti-vomiting, anti-motility or anti-diarrhoeal agents are not recommended and the administration of antibiotics is only supported in certain bacterial cases following microbiological advice. Measurement of UEC, blood sugar level (BSL) and FBC are recommended for dehydration >5%, with blood cultures if the temperature is >38·5°C.

Few Australian studies of nosocomial rotavirus infection are available. We found 10% of rotavirus infections were nosocomially acquired. Higher rates have been reported in other countries, including the United States (21%) [23] and Ireland (23%) [24]. Nosocomial rotavirus infection prolongs hospital stay and increases hospital costs [24, 25].

The accuracy and completeness of the medical records reviewed is largely unknown. This is a major limitation of the study and the result should be interpreted in this context. In 2004 there were fewer cases of rotavirus infection at the Children's Hospital at Westmead compared to other years. Although it cannot be determined precisely, this did not appear to be associated with changes in patterns of health-care delivery or testing in the hospital, but may have been due to a lower seasonal activity from rotavirus in that winter. Another limitation of this study is that it did not take into account those children presenting with symptoms of gastroenteritis whose stools were not tested, consequently a number of children presenting with mild to moderate gastroenteritis may have been excluded.

This study shows that a low percentage of patients with laboratory-confirmed disease had rotavirus enteritis as a primary diagnostic code (29%). This could lead to an underestimation of the incidence of rotavirus in reported statistics that rely on ICD-10 coding. A similar trend was reported by a study in the United States that evaluated the sensitivity of the rotavirus ICD code among children hospitalized for acute gastroenteritis [26]. In this study only 38% patients with laboratory-confirmed rotavirus disease were assigned a rotavirus code [26].

The rotavirus vaccine has recently been added to the NIP for all Australian infants. We would expect to see a reduction in the number and severity of cases of rotavirus presenting to hospital with the introduction of universal vaccination [27]. The data collected in this study may further inform the assessment of the rotavirus vaccination programme by providing information on the burden, management and outcomes of rotavirus disease.

ACKNOWLEDGEMENTS

A. T. N. was funded by a Public Health Postgraduate Scholarship (402920) from the National Health and Medical Research Council (NHMRC) of Australia, and by a GSK Support Grant. C.R.M. has had investigator-driven research funded by GSK and CSL/Merck, but this research did not involve rotavirus.

DECLARATION OF INTEREST

None.

References

1. Parashar, UD, et al. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 2003; 9: 565572.
2. Galati, JC, et al. The burden of rotavirus-related illness among young children on the Australian health care system. Australia & New Zealand Journal of Public Health 2006; 30: 416421.
3. Beers, MH, Berkow, R (eds) The Merck Manual of Diagnosis and Therapy, 17th edn. NJ: Merck Research Laboratories: Whitehouse Station, 1999.
4. Elliott, EJ, Backhouse, JA, Leach, JW. Pre-admission management of acute gastroenteritis. Journal of Paediatrics and Child Health 1996; 32: 1821.
5. Liddle, JLM, et al. Rotavirus gastroenteritis: impact on young children, their families and the health system. Medical Journal of Australia 1997; 167: 304307.
6. Velazquez, FR, et al. Rotavirus infections in infants as protection against subsequent infections. New England Journal of Medicine 1996; 335: 10221028.
7. Murphy, TV, et al. Intussusception among infants given an oral rotavirus vaccine. New England Journal of Medicine 2001; 344: 564752.
8. Ruiz-Palacios, GM, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 2006; 35: 1122.
9. Vesikari, T, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 1996; 354: 2333.
10. Australian Government Department of Health and Ageing. The Australian Immunisation Handbook, 8th edn. Canberra, 2003.
11. National Center for Health Statistics. The International Classification of Diseases, 9th revision, clinical modification. Ann Arbor, MI: US National Center for Health Statistics, 1978.
12. Ferson, MJ. Hospitalisations for rotavirus gastroenteritis among children under five of age in New South Wales. Medical Journal of Australia 1996; 164: 273276.
13. Ardern-Holmes, SL, et al. Trends in hospitalization and mortality from rotavirus disease in New Zealand infants. Pediatric Infectious Diseases Journal 1999; 18: 614619.
14. Malek, MA, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006; 117: 18871892.
15. Newall, AT, et al. Burden of severe rotavirus disease in Australia. Journal of Paediatrics and Child Health 2006; 42: 521.
16. Kirkwood, CN, et al. Report of the Australian Rotavirus Surveillance Program 2003–2004. Communicable Disease Intelligence 2004; 28: 481485.
17. Parashar, UD, et al. Rotavirus and severe childhood diarrhea. Emerging Infectious Diseases 2006; 12: 304306.
18. Jin, S, et al. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatric Infectious Diseases Journal 1996; 15: 397404.
19. Elliott, EJ, Dalby-Payne, JR. Acute infectious diarrhoea and dehydration in children. Medical Journal of Australia 2004; 181: 565570.
20. Gavin, N, Merrick, N, Davidson, B. Efficiacy of glucose-based oral rehydration therapy. Paediatrics 1996; 98: 4551.
21. Fonseca, BK, Holdgate, A, Craig, JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Archives of Pediatrics & Adolescent Medicine 2004; 158: 483490.
22. NSW Health Department. Acute management of young children and infants with gastroenteritis. Clinical practice guidelines, 2002.
23. Rodriguez-Baez, N, et al. Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. Journal of Pediatric Gastroenterology and Nutrition 2002; 35: 6468.
24. Harrington, M, Butler, K, Cafferkey, M. Rotavirus infection in hospitalised children: incidence and impact on healthcare resources. Irish Journal of Medical Science 2003; 172: 3336.
25. Gianino, P, et al. Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. Journal of Hospital Infection 2002; 50: 1317.
26. Hsu, VP, et al. Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics 2005; 115: 7882.
27. Newall, AT, et al. The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 2007; 25: 88518860.